Pediatrix Medical Group, Inc. (MD) on Decifer

Decifer ranks MD number 242 of 277 tracked names on durable business quality.

Why it ranks here

• It earns solid returns on the money it puts to work, around 10% and those returns have been improving and it turns most of its profit into real cash.
• Revenue is expected to grow about 2% a year, profits grew 263% over the past year, and growth is speeding up, not slowing down.
• It keeps a thin share of every sale as profit, and that has stayed steady over the years, a sign of real pricing power.
• and has the balance sheet to fund its growth.
• It is not watering down its owners with new shares and it returns cash to shareholders.
• Profits grew 263% off a low base but revenue is expected to grow only about 2%, returns are near 10%, and there is no worldview role to lift it.

The current read

The evidence on MD lines up on the supportive side: the intelligence feed flags this name as connected to what is moving markets now. The independent signals we track are telling the same story.

Themes

• Healthcare, Biotech & Devices: Pediatrix Medical Group, Inc. operates in medical - care facilities. That places it inside the Healthcare, Biotech & Devices story.

Read the full MD research brief · See all quality rankings

Intelligence data powered by Decifer. Not financial advice. For informational purposes only.